CIK: 0001482416
Total reported value
$697.3M
Reporting period: 2026-03-31 · Number of holdings: 76
Sio Capital Management, LLC disclosed 76 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $697.3M and a quarterly turnover rate of 94.1%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "S"
Sio Capital Management, LLC's disclosed holdings carry a Herfindahl concentration index of 0.030 — mathematically equivalent to about 33 equally-sized positions, well below its 76 actual disclosed holdings. That gap points to a strategy built around a small core of high-conviction bets rather than broad diversification.
Position sizes are fairly uniform across the portfolio (a coefficient of variation of 1.14), suggesting a disciplined, rules-based approach to how much capital goes into each idea.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 35% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Trim SNY
-75.3% -$35.5M
Trim ZBH
-83.8% -$29.0M
Trim CELC
-59.4% -$25.5M
Add COR
+534.6% $26.3M
Trim OGN
-74.7% -$19.3M
Add AVR
+187.1% $20.5M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | MMS | Maximus INC | Stock-Industrials | 7.07% | +0.28% | +53.67% | |
| 2 | WAY | Waystar Holding CORP | Stock-Other | 5.68% | +2.52% | +167.59% | |
| 3 | ICLR | ICON Public Limited Company | Stock-Healthcare | 4.86% | +1.21% | +140.84% | |
| 4 | COR | Cencora INC | Stock-Healthcare | 4.55% | +3.71% | +534.55% | |
| 5 | DNTH | Dianthus Therapeutics INC | Stock-Other | 4.45% | +1.37% | -22.01% | |
| 6 | AVR | Anteris Technologies Global | Stock-Other | 4.28% | +2.81% | +187.15% | |
| 7 | CORT | Corcept Therapeutics INC | Stock-Healthcare | 3.90% | +3.90% | NEW | |
| 8 | LIVN | LivaNova PLC | Stock-Other | 3.84% | +0.72% | +30.78% | |
| 9 | TYRA | Tyra Biosciences INC | Stock-Other | 3.33% | +1.15% | +15.10% | |
| 10 | CELC | Celcuity INC | Stock-Other | 3.17% | -4.31% | -59.37% | |
| 11 | GSK | Gsk Plc-spon Adr | Stock-Healthcare | 3.05% | +3.05% | NEW | |
| 12 | ANIP | Ani Pharmaceuticals INC | Stock-Other | 2.93% | +1.85% | +204.27% | |
| 13 | ABT | Abbott Laboratories | Stock-Healthcare | 2.75% | +2.75% | NEW | |
| 14 | EMBC | Embecta CORP | Stock-Healthcare | 2.34% | +2.34% | NEW | |
| 15 | ABVX | Abivax Sa-adr | Stock-Other | 2.17% | +1.26% | +214.91% | |
| 16 | VIR | Vir Biotechnology INC | Stock-Other | 1.93% | +1.48% | +213.29% | |
| 17 | HAE | Haemonetics Corp/mass | Stock-Other | 1.78% | +0.61% | +138.23% | |
| 18 | SION | Sionna Therapeutics INC | Stock-Other | 1.69% | +1.69% | NEW | |
| 19 | SNY | Sanofi-adr | Stock-Healthcare | 1.66% | -5.75% | -75.33% | |
| 20 | RAPP | Rapport Therapeutics INC | Stock-Other | 1.65% | +0.77% | +97.99% | |
| 21 | TFX | Teleflex INC | Stock-Healthcare | 1.63% | — | +9.12% | |
| 22 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 1.57% | -0.61% | -16.53% | |
| 23 | CCRN | Cross Country Healthcare INC | Stock-Other | 1.48% | — | +2.77% | |
| 24 | TARA | Protara Therapeutic INC | Stock-Other | 1.47% | — | +14.83% | |
| 25 | GPCR | Structure Therapeutics INC | Stock-Other | 1.45% | -0.75% | +3.77% | |
| 26 | BHVN | Biohaven Ltd. | Stock-Other | 1.41% | -0.80% | -6.49% | |
| 27 | MNPR | Monopar Therapeutics INC | Stock-Other | 1.36% | +1.36% | NEW | |
| 28 | EYPT | Eyepoint INC | Stock-Other | 1.33% | +1.33% | NEW | |
| 29 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 1.30% | +0.39% | +100.16% | |
| 30 | EWTX | Edgewise Therapeutics INC | Stock-Other | 1.22% | +0.29% | +13.27% | |
| 31 | CMPS | Compass Pathways PLC | Stock-Other | 1.19% | +1.19% | NEW | |
| 32 | OCUL | Ocular Therapeutix INC | Stock-Other | 1.18% | +1.18% | NEW | |
| 33 | AQST | Aquestive Therapeutics INC | Stock-Other | 1.14% | — | +93.63% | |
| 34 | RLMD | Relmada Therapeutics INC | Stock-Other | 0.96% | +0.96% | NEW | |
| 35 | ORKA | Oruka Therapeutics INC | Stock-Other | 0.93% | +0.37% | +12.16% | |
| 36 | ZBIO | Zenas Biopharma INC | Stock-Other | 0.93% | +0.93% | NEW | |
| 37 | DRUG | Bright Minds Biosciences INC | Stock-Other | 0.90% | — | +5.13% | |
| 38 | QDEL | Quidelortho CORP | Stock-Other | 0.85% | +0.85% | NEW | |
| 39 | ZBH | Zimmer Biomet Holdings INC | Stock-Healthcare | 0.81% | -4.64% | -83.76% | |
| 40 | REPL | Replimune Group INC | Stock-Other | 0.79% | +0.79% | NEW | |
| 41 | OGN | Organon & Co | Stock-Healthcare | 0.74% | -3.12% | -74.69% | |
| 42 | OKUR | Onkure Therapeutics Inc-a | Stock-Other | 0.64% | +0.64% | NEW | |
| 43 | IRON | Disc Medicine INC | Stock-Other | 0.60% | — | +13.23% | |
| 44 | PMVP | Pmv Pharmaceuticals INC | Stock-Other | 0.55% | — | +16.69% | |
| 45 | IMNM | Immunome INC | Stock-Other | 0.52% | +0.52% | NEW | |
| 46 | IART | Integra Lifesciences Holding | Stock-Other | 0.52% | +0.52% | NEW | |
| 47 | SVRA | Savara INC | Stock-Other | 0.48% | — | — | |
| 48 | CNC | Centene CORP | Stock-Healthcare | 0.47% | -1.31% | -63.55% | |
| 49 | ✓ | Proqr Thrapeutics N V | Stock-Other | 0.45% | — | -9.68% | |
| 50 | SI | Shoulder Innovations INC | Stock-Other | 0.44% | — | -7.60% |
Performance for Q3 2026
+13.6%
Performance Last 4 Quarters
+86.5%
Based on 76% of reported portfolio value with available pricing
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 76 | $697.3M | 94 | |
| 2025-12-31 | 68 | $635.7M | 96 | |
| 2025-09-30 | 51 | $395.2M | 100 | |
| 2025-06-30 | 52 | $261.8M | 0 | |
| 2025-03-31 | 54 | $335.8M | 100 | |
| 2024-12-31 | 51 | $355.4M | 0 | |
| 2024-09-30 | 39 | $252.2M | 0 | |
| 2024-06-30 | 48 | $369.5M | 0 | |
| 2024-03-31 | 51 | $335.8M | 0 | |
| 2023-12-31 | 43 | $439.2M | 0 | |
| 2023-09-30 | 52 | $323.1M | 0 | |
| 2023-06-30 | 47 | $393.2M | 0 | |
| 2023-03-31 | 44 | $202.3M | 0 | |
| 2022-12-31 | 47 | $270.4M | 0 | |
| 2022-09-30 | 49 | $314.7M | 0 | |
| 2022-06-30 | 62 | $266.2M | 0 | |
| 2022-03-31 | 66 | $302.3M | 0 | |
| 2021-12-31 | 70 | $331.7M | 0 | |
| 2021-09-30 | 61 | $313.7M | 0 | |
| 2021-06-30 | 74 | $402.3M | 70 | |
| 2021-03-31 | 89 | $492.7M | 71 | |
| 2020-12-31 | 89 | $488.5M | 79 | |
| 2020-09-30 | 89 | $505.0M | 86 | |
| 2020-06-30 | 78 | $342.7M | 94 | |
| 2020-03-31 | 69 | $298.4M | 100 | |
| 2019-12-31 | 69 | $419.8M | 93 | |
| 2019-09-30 | 63 | $310.5M | 100 | |
| 2019-06-30 | 71 | $414.8M | 100 | |
| 2019-03-31 | 70 | $370.4M | 98 | |
| 2018-12-31 | 69 | $274.5M | 100 | |
| 2018-09-30 | 64 | $291.5M | 100 | |
| 2018-06-30 | 49 | $180.9M | 100 | |
| 2018-03-31 | 31 | $166.4M | 100 | |
| 2017-12-31 | 45 | $177.3M | 100 | |
| 2017-09-30 | 54 | $192.7M | 100 | |
| 2017-06-30 | 58 | $210.4M | 92 | |
| 2017-03-31 | 46 | $178.8M | 100 | |
| 2016-12-31 | 43 | $171.4M | 93 | |
| 2016-09-30 | 32 | $145.0M | 91 | |
| 2016-06-30 | 43 | $195.8M | 100 | |
| 2016-03-31 | 42 | $273.2M | 100 | |
| 2015-12-31 | 42 | $225.8M | 100 | |
| 2015-09-30 | 35 | $145.9M | 100 | |
| 2015-06-30 | 39 | $202.4M | 100 | |
| 2015-03-31 | 30 | $175.7M | 100 | |
| 2014-12-31 | 30 | $127.3M | 0 |
Sio Capital Management, LLC's most significant position changes for 2026-03-31: Sold out: THE Cigna Group (CI); Sold out: Rhythm Pharmaceuticals INC (RYTM); New buy: Corcept Therapeutics INC (CORT); Sold out: Kenvue INC (KVUE); New buy: Gsk Plc-spon Adr (GSK).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | COR | Cencora INC | +3.7% | +534.55% | Add |
| 2 | AVR | Anteris Technologies Global | +2.8% | +187.15% | Add |
| 3 | WAY | Waystar Holding CORP | +2.5% | +167.59% | Add |
| 4 | ANIP | Ani Pharmaceuticals INC | +1.9% | +204.27% | Add |
| 5 | VIR | Vir Biotechnology INC | +1.5% | +213.29% | Add |
| 6 | DNTH | Dianthus Therapeutics INC | +1.4% | -22.01% | Trim |
| 7 | ABVX | Abivax Sa-adr | +1.3% | +214.91% | Add |
| 8 | ICLR | ICON Public Limited Company | +1.2% | +140.84% | Add |
| 9 | TYRA | Tyra Biosciences INC | +1.2% | +15.10% | Add |
| 10 | RAPP | Rapport Therapeutics INC | +0.8% | +97.99% | Add |
| 11 | LIVN | LivaNova PLC | +0.7% | +30.78% | Add |
| 12 | HAE | Haemonetics Corp/mass | +0.6% | +138.23% | Add |
| 13 | CRNX | Crinetics Pharmaceuticals In | +0.4% | +100.16% | Add |
| 14 | ORKA | Oruka Therapeutics INC | +0.4% | +12.16% | Add |
| 15 | EWTX | Edgewise Therapeutics INC | +0.3% | +13.27% | Add |
| 16 | MMS | Maximus INC | +0.3% | +53.67% | Add |
| 17 | BMRN | Biomarin Pharmaceutical INC | -0.6% | -16.53% | Trim |
| 18 | GPCR | Structure Therapeutics INC | -0.8% | +3.77% | Add |
| 19 | BHVN | Biohaven Ltd. | -0.8% | -6.49% | Trim |
| 20 | CNC | Centene CORP | -1.3% | -63.55% | Trim |
| 21 | OGN | Organon & Co | -3.1% | -74.69% | Trim |
| 22 | CELC | Celcuity INC | -4.3% | -59.37% | Trim |
| 23 | ZBH | Zimmer Biomet Holdings INC | -4.6% | -83.76% | Trim |
| 24 | SNY | Sanofi-adr | -5.8% | -75.33% | Trim |
| 25 | CI | THE Cigna Group | — | EXIT | Sold out |
| 26 | RYTM | Rhythm Pharmaceuticals INC | — | EXIT | Sold out |
| 27 | CORT | Corcept Therapeutics INC | — | NEW | New buy |
| 28 | KVUE | Kenvue INC | — | EXIT | Sold out |
| 29 | GSK | Gsk Plc-spon Adr | — | NEW | New buy |
| 30 | ABT | Abbott Laboratories | — | NEW | New buy |
| 31 | EMBC | Embecta CORP | — | NEW | New buy |
| 32 | SION | Sionna Therapeutics INC | — | NEW | New buy |
| 33 | BTSG | Brightspring Health Services | — | EXIT | Sold out |
| 34 | CRL | Charles River Laboratories | — | EXIT | Sold out |
| 35 | MNPR | Monopar Therapeutics INC | — | NEW | New buy |
| 36 | EYPT | Eyepoint INC | — | NEW | New buy |
| 37 | CMPS | Compass Pathways PLC | — | NEW | New buy |
| 38 | OCUL | Ocular Therapeutix INC | — | NEW | New buy |
| 39 | RLMD | Relmada Therapeutics INC | — | NEW | New buy |
| 40 | ZBIO | Zenas Biopharma INC | — | NEW | New buy |
| 41 | QDEL | Quidelortho CORP | — | NEW | New buy |
| 42 | REPL | Replimune Group INC | — | NEW | New buy |
| 43 | MCK | Mckesson CORP | — | EXIT | Sold out |
| 44 | OKUR | Onkure Therapeutics Inc-a | — | NEW | New buy |
| 45 | FULC | Fulcrum Therapeutics INC | — | EXIT | Sold out |
| 46 | IMNM | Immunome INC | — | NEW | New buy |
| 47 | IART | Integra Lifesciences Holding | — | NEW | New buy |
| 48 | VTYXUSD | Ventyx Biosciences INC | — | EXIT | Sold out |
| 49 | ALKS | Alkermes plc | — | EXIT | Sold out |
| 50 | IDYA | Ideaya Biosciences INC | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-14 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-17 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-13 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-13 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-15 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-14 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-14 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-14 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-15 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-13 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-14 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-14 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-12 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-13 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-15 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-16 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-14 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-15 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-08-16 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-14 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-16 | 13F-HR | View on EDGAR |
| 2020-09-30 | 2020-11-16 | 13F-HR | View on EDGAR |
| 2020-06-30 | 2020-08-14 | 13F-HR | View on EDGAR |
| 2020-03-31 | 2020-05-15 | 13F-HR | View on EDGAR |
| 2019-12-31 | 2020-02-14 | 13F-HR | View on EDGAR |
| 2019-09-30 | 2019-11-14 | 13F-HR | View on EDGAR |
| 2019-06-30 | 2019-08-14 | 13F-HR | View on EDGAR |
| 2019-03-31 | 2019-05-15 | 13F-HR | View on EDGAR |
| 2018-12-31 | 2019-02-14 | 13F-HR | View on EDGAR |
| 2018-09-30 | 2018-11-14 | 13F-HR | View on EDGAR |
| 2018-06-30 | 2018-08-14 | 13F-HR | View on EDGAR |
| 2018-03-31 | 2018-05-15 | 13F-HR | View on EDGAR |
| 2017-12-31 | 2018-02-14 | 13F-HR | View on EDGAR |
| 2017-09-30 | 2017-11-14 | 13F-HR | View on EDGAR |
| 2017-06-30 | 2017-08-14 | 13F-HR | View on EDGAR |
| 2017-03-31 | 2017-05-15 | 13F-HR | View on EDGAR |
| 2016-12-31 | 2017-02-14 | 13F-HR | View on EDGAR |
| 2016-09-30 | 2016-11-15 | 13F-HR | View on EDGAR |
| 2016-06-30 | 2016-08-15 | 13F-HR | View on EDGAR |
| 2016-03-31 | 2016-05-16 | 13F-HR | View on EDGAR |
| 2015-12-31 | 2016-02-16 | 13F-HR | View on EDGAR |
| 2015-09-30 | 2015-11-13 | 13F-HR | View on EDGAR |
| 2015-06-30 | 2015-08-14 | 13F-HR | View on EDGAR |
| 2015-03-31 | 2015-05-15 | 13F-HR | View on EDGAR |
| 2014-12-31 | 2015-02-17 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001767080
Total reported value
$697.2M
246 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001729869
Total reported value
$697.4M
100 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001542324
Total reported value
$697.1M
199 stks
2026-06-30
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0000740272
Total reported value
$684.3M
101 stks
2026-03-31
1 of the top 5 holdings overlap, including ICON Public Limited Company
CIK 0000790502
Total reported value
$19.6B
547 stks
2024-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Cencora INC
CIK 0000928204
Total reported value
$347.5M
129 stks
2016-12-31
Stale — no recent filing
1 of the top 5 holdings overlap, including Cencora INC